// App-Quantinova.ai

112 : Circulating and molecular markers of inflammation: impact on treatment response and survival among older patients with cancer treated with immune checkpoint inhibitors

Researchers

Presenter

  • Khalil Choucair

Principal Investigators

  • Alessio Cortellini

  • Stijn Hentzen

  • Yinghong Wang

  • April Salama

  • Andrew Elliott

  • Matthew Oberley

  • Phillip Walker

  • Raza Bokhari

  • Raffaele Giusti

  • Marco Filetti

  • Paolo Ascierto

  • Vito Vannella

  • Domenico Galetta

  • Annamaria Catino

  • Pamela Pizzutilo

  • Carlo Genova

  • Melissa Bersanelli

  • Sebastiano Buti

  • Azhaar Saeed

  • Wafik El-Deiry

  • Himisha Beltran

  • Chadi Nabhan

  • Douglas Johnson

  • Claudia Fulgenzi

  • David Pinato

  • Maluki Radford

  • Stephen Liu

  • Chul Kim

  • Rafeh Naqash

  • Anwaar Saeed

Medical Centers

  • University of Minnesota, Minneapolis, MN

  • University of Oklahoma, Stephenson Cancer Center, Oklahoma City, OK

  • 1.MD Anderson Cancer Center, Houston, TX

  • Georgetown University, Washington, DC

  • University Hospital of Parma, Parma, Italy

  • Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy

  • Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

  • Duke Cancer Institute, Durham, NC

  • Karmanos Cancer Institute, Wayne State University, Detroit, MI

  • Kansas University Cancer Center, Fairway, KS, USA

  • Caris Life Sciences, Phoenix, AZ

  • Hammersmith Hospital Campus, Imperial College London, London, UK

  • Vanderbilt-Ingram Cancer Center, Nashville, TN

  • Azienda Ospedaliera-Universitaria Sant'Andrea, ROMA, Italy

  • Hammersmith Hospital, Imperial College London; Fondazione Policlinico Campus Bio-Medico, London, UK

  • Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy

  • Dana-Farber Cancer Institute, Boston, MA

  • Cancer Center at Brown University, Providence, PA

Locations

  • United States

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Renal cell carcinoma

  • Lung Cancer

  • Solid malignancies

  • Melanoma

Biomarkers

  • Neutrophil lymphocyte ratio

  • Platelet-lymphocyte ratio

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved